Nextpoint Therapeutics

Developer of immuno-therapeutics for cancer treatment

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups11 employees language nextpointtx.com

Registered entities

Social engagement

Social engagement: 4.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Catalio Capital Management, Sanofi Ventures, Bayer.

Investor typeCountShare
Venture capital750%
Private equity321%
Other / undisclosed429%

Recent activity

14 May 2026
Event
Fierce Biotech Week
1 May 2026
Event
Fierce Biotech Week panel
17 Apr 2026
Event
AACR
Coming soon